"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Progress in Wholly-owned Subsidiary's Clinical Trial for VUM02 Injection

About this update from Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

Announcement on Progress in Wholly-owned Subsidiary's Clinical Trial for VUM02 InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Vcanbio Cell & Gene Engineering Corp., Ltd. Class A